A brand new stereotactic radio-surgery centre ‘Sigulda’ has opened in Latvia. This centre offers the most modern technology found in Baltic States to cure benign and malignant tumours.
CyberKnife technology is a non-invasive form of radiosurgery – perfect for patients suffering from tumours that cannot be operated on conventionally, especially if the tumour is located somewhere hard to reach and if invasive surgery poses a risk for the patient’s health.
Latvian physicians say patients will benefit the most from this high-tech centre. Head of Pauls Stradins Clinical University Hospital’s Diagnostic Radiology Institute Dr. Karlis Kupcs says: «This technology presents an opportunity Latvian patients have not had before.»
CyberKnife technology allows specialists to administer high doses of ionizing radiation to precise and localized tumour areas. Accuracy of this technology is 0.5 to 0.95mm. During the treatment process, the device carefully follows each movement of the body, adapting its aim and reducing radiation exposure to tissues situated close to the tumour.
CyberKnife’s main advantage is reaching surgically inaccessible tumours. Treatment is administered over a course of 1-5 sessions. On top of that, there is no need for the patient to remain hospitalized. This treatment technology also creates fewer complications and provides the patient with higher life quality indexes after treatment. After the 30-45 minute treatment session, patients can safely return to their everyday lives.
Procurement of necessary technology and construction of the centre in Sigulda cost EUR 5.6 million. EUR 3.8 million was provided by Citadele as a loan and EUR 1.8 million is private capital. This project was realized as part of the 4th stage of added value investments of the Latvian Investments and Development Agency and with co-financing from European Regional Development Fund. LIAA’s funding of EUR 2.13 million will be allocated after the project’s completion and will be used to cover the loan provided by Citadele.